Anti-CD7 Antibody is a monoclonal antibody specifically recognizing the CD7 surface antigen, which is highly expressed in T-cell acute lymphoblastic leukemia (T-ALL) and some acute myeloid leukemias. This antibody is primarily used for developing targeted therapeutic strategies, such as antibody-drug conjugates (ADCs) or nanobody drugs, aimed at precisely clearing malignant T-lymphocytes while minimizing toxicity to normal hematopoietic stem cells.